Correspondence 0001213900-22-073451 from REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC.
Date: Nov. 17, 2022 · CIK: 0001810560 · Accession: 0001213900-22-073451
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-268076
Letter
Revelation Biosciences, Inc.
4660 La Jolla Village Drive
San Diego, California 92122
November 17, 2022
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Office of Life Sciences
Re: Revelation Biosciences, Inc.
Registration Statement on Form S-1
Commission File No. 333-268076
Ladies and Gentlemen:
On behalf of Revelation Biosciences, Inc., I hereby request that the Commission declare effective the above-captioned registration statement at 4:00pm on November 18, 2022, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Revelation Biosciences, Inc.
4660 La Jolla Village Drive
San Diego, California 92122
November 17, 2022
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Office of Life Sciences
Re: Revelation Biosciences, Inc.
Registration Statement on Form S-1
Commission File No. 333-268076
Ladies and Gentlemen:
On behalf of Revelation Biosciences, Inc., I hereby request that the Commission
declare effective the above-captioned registration statement at 4:00pm on November 18, 2022, or as soon thereafter as practicable. Please
call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
/s/ Chester S. Zygmont, III
Chief
Financial Officer